about
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Com...
Read More
7.13
0.23
(3.33%)
20,864
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Passage Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..